There is new, compelling evidence to suggest that all men who use testosterone therapy products have an increased risk of life-threatening blood clots. This remains true regardless of whether the patients have been diagnosed with hypogonadism or not. Testosterone therapy products, which include Axiron, Androgel, and Testim, have been under... Read more »

Thousands of plaintiffs who have filed lawsuits regarding Nexium, Prilosec, and similar medications have been looking forward to having their claims heard in court. However, the process of selecting cases for bellwether trials has hit a snag. Originally, the court instructed the involved parties to submit their final, agreed-upon plan... Read more »

Daily use of talcum powder for over 30 years has resulted in a case of ovarian cancer, alleges a new lawsuit filed against Johnson & Johnson and Imerys Talc America. The plaintiff, Rebecca Lichtenfels, filed her product liability lawsuit in the U.S. District Court for the District of Columbia on... Read more »

A resident of Delaware claims that the popular shingles vaccine, Zostavax, caused him to develop severe problems with his eyes and vision. Leroy Crawley filed his product liability lawsuit on January 3, 2019 in the U.S. District Court for the Eastern District of Pennsylvania, where it joins other Zostavax lawsuits... Read more »

A motion was recently filed with the U.S. Judicial Panel on Multidistrict Litigation (JPML) that seeks to consolidate federal complaints filed with regard to valsartan, a generic hypertension drug. The motion was filed late in October 2018 by Robert Kruk on behalf of himself and other plaintiffs with pending valsartan lawsuits. Kruk... Read more »

There are more than 10,000 talc powder lawsuits pending against Johnson & Johnson. Most of them are pending in the multidistrict litigation (MDL) in federal court, and the rest are pending in state courts around the country. The product liability lawsuits raise similar claims: That Johnson & Johnson’s Baby Powder... Read more »

The U.S. Food and Drug Administration (FDA) recently issued a new safety alert regarding the increased risk of Fournier’s gangrene among diabetes patients using Invokana and other drugs in the same class. Fournier’s gangrene is considered to be a rare, but very serious complication of SGLT2 inhibitors. This condition is... Read more »

Hundreds of testosterone lawsuits have been officially resolved now that the master settlement agreement has been finalized, as of late July 2018. The settlement agreement only applies to Androderm lawsuits filed against Actavis and Allergan. Thousands of other testosterone lawsuits have been filed against other manufacturers in recent years. This... Read more »

Actavis, the makers of Androderm, has announced that there is a tentative settlement agreement in place that would resolve roughly 500 lawsuits. The plaintiffs involved with the litigation allege that they suffered serious complications as a result of their use of the defendants’ medicated testosterone patch. Actavis, which was acquired... Read more »

Twenty-two women who developed ovarian cancer that they claim was caused by Johnson & Johnson’s talcum powder products will have their day in court soon. Jury selection for the state court trial is set to begin this week. The trial is expected to last about six weeks. During the trial,... Read more »